Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Castleark Management LLC Increases Position in Ascendis Pharma A/S $ASND
Castleark Management LLC increased its stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 55.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned…
Rhenman & Partners Asset Management AB Decreases Stock Holdings in Royalty Pharma PLC $RPRX
Rhenman & Partners Asset Management AB trimmed its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 20.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 206,500 shares…
Rhenman & Partners Asset Management AB Purchases New Shares in Ascendis Pharma A/S $ASND
Rhenman & Partners Asset Management AB purchased a new stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased…
Rosenblatt Raises its Price Target on The Walt Disney Company (DIS)
The Walt Disney Company (NYSE:DIS) is one of the On June 5, 2026, Rosenblatt raised the firm's price target on The Walt Disney Company (NYSE:DIS) to $126 from $121 and maintained a Buy rating on the shares. The firm said Disney's current movie…
Is Corvus Pharmaceuticals, Inc. (CRVS) A Good Stock To Buy Now?
Is CRVS a good stock to buy? We came across a bullish thesis on Corvus Pharmaceuticals, Inc. on Biotech Distilled's Substack. In this article, we will summarize the bulls' thesis on CRVS. Corvus Pharmaceuticals, Inc.'s share was trading at $11.15…
Goldman says stocks like Nvidia have more room to run
Goldman Sachs named several stocks that are well positioned in the current market environment. The investment bank says companies like Samsara have defensive qualities while also offering plenty of upside. Other stocks rated buy at Goldman Sachs…
US' Biolab Network Used to Target Enemies Worldwide, Ukraine Just the Tip of the Iceberg
The US “benefits from having some of the most dangerous pathogens known to man, to attack the West's many perceived enemies,” Brown explained, pointing to allegations of the US using swine fever and avian flu to target China in recent…
Drugmakers race to find a place in the next wave of obesity drugs
Eli Lilly, Novo Nordisk, Amgen, Zealand, Structure Therapeutics shared their visions for the future of obesity medicine. Drugmakers pitched doctors and investors on their future drugs at the recent American Diabetes Association (ADA) Scientific…
Viral influencer: How Bill Gates' billions shape U.S. medical research * WorldNetDaily * by Paul D. Thacker, Real Clear Wire
Bill Gates has long been one of the most admired people in the world, especially since he stepped down from his role running Microsoft to devote himself and much of his fortune to philanthropy. That reputation has been tarnished recently, however…
3 Stocks With a Yield Over 6% For Passive Income Investors
Passive income arrives while you sleep, commute, or vacation. That appeal drives dividend investing: a paycheck every quarter regardless of market conditions or work hours. Layoff announcements have rattled white-collar industries through the first…
Teva Pharmaceutical Industries Ltd. $TEVA Shares Acquired by Clal Insurance Enterprises Holdings Ltd
Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 18.8% in the fourth quarter, according to the company in its most recent filing with the Securities and…
India's productivity gap with China widens despite strong GDP growth: Equirus Securities
India's labour productivity gap with China has widened by more than $30,000 per worker since 2000, despite decades of strong economic growth, with the country yet to achieve the industry-led productivity transformation seen in economies such as…
64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.
A 64-year-old software executive walks out of the office on her last day with $1.6 million sitting in a single employer stock. Her cost basis is $240,000, meaning roughly $1.36 million is embedded long-term capital gain waiting to be triggered. She…
Dividend Safety Check: FNDF and International Large-Cap Dividend Income
FNDF's fundamental weighting targets mature cash generators, delivering a safe aggregate distribution alongside a 40% one-year total return. HSBC's Q1 EPS missed consensus by 81% while Shell raised its quarterly dividend, revealing uneven safety…
Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years
Paying $2,000 a month in rent is often described as throwing money away. Homeownership, by contrast, is treated as the only reliable path to wealth. Yet under the right conditions, a dividend portfolio large enough to cover your rent can leave you…
Receive a Daily briefing on Pharma Industry News
Get Started